A tweet and a chart to think about.
Was traveling in midwest y'day to see ISI clients. Huge generalist interest in biotech & pharma right now. I mean off the charts.Mark Schoenebaum (@MarkSchoenebaum) February 20, 2014
Cramer shares his views on Oracle's re-rating and also discusses the constant battle between growth and value.
Jim Cramer discusses not discussing the 'market' and also suggests a Darth Vader-Amazon meeting.
Healthcare leads markets after the release of the Senate health plan.